Tenon Medical Inc (TNON) Quote

You pump it with this post and then bash it after you sell,you should be ashamed of yourself!!

Doesn't nothing bud, company is dying for cash and revenues. Shorts don't care, they will choke it to death and another dilution.

nuts..t**p just on time.. lol
TNON

ZERO BORROW again,death hr over in 8min,watch for demand now

Out with 900 dollar loss.

Great I’ll get some funds ready!
TNON

Thanks for sharing!!
TNON

Cost to Borrow is over 500%. No way but up, if not tomorrow and if we get decent enough volume between tomorrow and Thursday, this might even hit 25-30 dollars. Once covering starts with volume, this will spike hard. They tested it after hours, it shot up to over 12 dollars in seconds.

Huge squeeze in-bound this week and all next week. Mark it. Without a doubt in my mind. Company had to do an offering to meet minimum float as Nasdaq required and one institution/hedge fund, scooped them up.

https://finance.yahoo.com/quote/TNON/holders/

Bought TNONW(warrents)under .04,TNON is zero borrow today,record buying volume last week and volume continues today

TNON and other great companies.

I sent you an email from my business account.

I expect some news this week. This is bound to hit double digits.

Double digits this week.

$TNON starts again ❤️
imo

Read back and understand the context

You own the company?

I do. PM me your email address

and I will email you information on our rapidly growing company.

#TNON 🔥 from $2 to $134! Monday can $TNON move again?

At $40 thought it would rebound and head back up. This was a trappers trap

Short attention span folks have moved on

That is huge Boston! Do you own that Company? tia🥰

A public robbery was just had … total outstanding traded 20x times and vwap nearly $11 .. as it continues to sink

Ugliest chart on the planet

Thanks. I've always liked this company.

My company makes a medical device used by doctors for cancer patients. I even tried to partner with them. As you said, there are plenty of fish.

So $100+ wasn't my imagination? 😂

Offloaded some, making sure my profits are locked.

Geez Boston. I am sorry to hear this but there are many other fish in the sea!

Great NEWS. I have been holding

this for many monrhs, recently sold, and totally missed this.

Next Week 20$+

Pyjama traders LOL

Next 3 tradings days getting wild

Who shorted $129.99 ? and who covered@$13.44?

400k float can do wonders

We need to get back there.

$120s for a minute lol. Hedgies really pushed it out gate

Did this reach $120?

WOAH!!!!

Hello 911 what’s your emergency? Quick. Securities fraud taking place

Crooks

Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
LOS GATOS, CA / ACCESSWIRE / September 12, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 1,222,850 shares of common stock at a combined offering price of $3.68 per share and accompanying warrant, priced at-the-market under Nasdaq rules (the "Offering"). The Company expects to receive aggregate gross proceeds of approximately $4.5 million, before deducting placement agent fees and other offering expenses, and assuming no exercise of the warrants. The warrants will have an exercise price of $3.55 per share, will be exercisable immediately and will expire five years from the issuance date.

The closing of the Offering is expected to occur on or about September 16, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from this Offering for commercial activity, working capital and general corporate purposes.

A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offering.

The securities described above are being offered pursuant to a registration statement on Form S-1 (File No. 333-281531) previously filed with the Securities and Exchange Commission ("SEC") which was declared effective on September 12, 2024. This Offering is being made only by means of a prospectus forming part of the effective registration statement. Copies of the preliminary prospectus and, when available, copies of the final prospectus, relating to the Offering may be obtained on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus relating to the Offering may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@allianceg.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Who the hell filled 129.99

Hahahahahahah

Wow and wtf

Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System
~ New SI Joint Fixation Device Offers a 30% Reduction in Implant Size Providing Physicians Choices for Varying Anatomy and Treatment Strategies with the Catamaran Technology ~

~The SE System Can Also Be Utilized with a Manual Drilling Option During Implant Preparation~

LOS GATOS, CA / ACCESSWIRE / September 12, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced preparation for the initial alpha launch of the Company's new Catamaran SE SI Joint Fusion System targeted for the beginning of Q4. The Catamaran SE Fixation Device extends the line of implant offerings for physicians preferring a smaller Catamaran implant when performing a SI joint fusion procedure. The new implant offers a 30% reduction in implant width as compared to the original Catamaran fixation device, providing physicians options for smaller SI joint anatomy or revising previously treated SI joints with failed alternative SI joint implants where space is limited. The SE implant also comes with a hand drill option for those physicians who prefer to manually drill during implant preparation or do not have power sources readily available in their treating sites of care.

The alpha launch of the Catamaran SE will provide important initial user feedback from a select group of physician users to support a broader market launch in the coming months. This news of the Catamaran SE comes on the recent announcement by the Company of the Catamaran SI Joint Fusion System MAINSAIL Study's positive interim outcomes publication. Click here to view the publication in its entirety.

The Catamaran and Catamaran SE SI Joint Fixation devices are single robust fully MRI compatible titanium implants comprised of two pontoons, connected by an osteotome bridge, which is designed to transfix the SI joint along its longitudinal axis providing immediate fixation and stabilization of the joint, with the aim of achieving a successful long-term fusion. The Catamaran implant was developed with respect to AO principles of arthrodesis including 1) adequate joint preparation, 2) rigid fixation and stabilization, and 3) adequate bone graft augmentation. Via a minimally invasive inferior-posterior approach the Catamaran & Catamaran SE implant are delivered within the dense cortical bone of the sacrum and ilium, to transfix and stabilize the SI joint for the treatment of SIJ dysfunction. To date there have been over 700 Catamaran fixation devices implanted to treat primary SI Joint dysfunction and sacroiliitis, as well as revise previously treated SI joints with failed alterative SI joint implants.

Bryan Hoelzer, MD, Interventional Pain Physician and Medical Director of Southwest Spine and Pain Center, in Provo, UT., commented, "The clinical evidence validating the safety and efficacy of the inferior-posterior approach to treat SI Joint disease continues to grow with the recent Catamaran MAINSAIL Study publication. Continued advancement in implant technology as seen in the smaller Catamaran SE Fixation Device is exciting and will provide more improved options for myself and, my patients in treating and managing their painful SI joint disorders."and the entire interventional pain community."

Steven M. Foster, President and CEO of Tenon Medical, stated, "As a leader in the SI joint fusion market it is critical that we continually listen to input from our customers and respond with innovative technology that benefits their patients. The development and introduction of the Catamaran SE SI Joint Fusion System will provide our physician users with more choices to treat their patients with SI Joint disease. We look forward to a successful limited alpha launch and then move rapidly to a full market introduction."

About Tenon Medical, Inc.

News!

https://www.otcmarkets.com/stock/TNON/news/story?e&id=2980608

----------------------------------------------

Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System

~ New SI Joint Fixation Device Offers a 30% Reduction in Implant Size Providing Physicians Choices for Varying Anatomy and Treatment Strategies with the Catamaran Technology ~

~The SE System Can Also Be Utilized with a Manual Drilling Option During Implant Preparation~

LOS GATOS, CA / ACCESSWIRE / September 12, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced preparation for the initial alpha launch of the Company's new Catamaran SE SI Joint Fusion System targeted for the beginning of Q4. The Catamaran SE Fixation Device extends the line of implant offerings for physicians preferring a smaller Catamaran implant

Halt again!

The company is now forced to issue

more shares because of the RS. That is a double whammy.

On September 9, 2024, Tenon Medical, Inc. (the “Company”) received a letter from the listing qualifications staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) providing notification that the Company does not currently meet the minimum 500,000 publicly held shares requirement pursuant to Nasdaq Listing Rule 5550(a)(4) (the “Minimum Float Requirement”). As a result of the 1-for-8 reverse stock split of the Company’s common stock on September 6, 2024, the aggregate number of the Company’s outstanding shares of common stock was reduced from 4,081,767 shares on a pre-reverse-split basis to a total of 510,221 shares outstanding on a post-reverse split basis, with 490,364 of such shares currently qualifying as publicly held shares for purposes of the Minimum Float Requirement. The Staff has given us until October 24, 2024, to provide the Staff with a specific plan to regain compliance of the Minimum Float Requirement.



The Company expects to regain compliance with the Minimum Float Requirement in September through the consummation of a public offering of its common stock pursuant to its Registration Statement on Form S-1 (No. 333-281531), originally filed on August 14, 2024.



The Nasdaq notification has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market.

Lol

TNON new 52 week low